𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Response: Philadelphia chromosome excludes the diagnosis of essential thrombocythemia

✍ Scribed by Ravindra Sarode; Neelam Marwaha

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
69 KB
Volume
35
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Thiotepa for the treatment of thrombocyt
Thiotepa for the treatment of thrombocythemia in patients with Philadelphia chromosome positive chronic myelogenous leukemia
✍ Edgardo J. Rodriguez-Monge; Jorge E. Cortes; Susan O'Brien; Moshe Talpaz; Hagop πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 3 views

## Background: Patients with chronic myelogenous leukemia (cml) occasionally experience persistent thrombocythemia despite having adequate white blood cell (wbc) counts. trimethylenethiophosphoramide (thiotepa) is an alkylating agent that significantly inhibits platelet production. ## Methods: Th

Leukocytosis at diagnosis and the risk o
Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera
✍ Naseema Gangat; Alexandra P. Wolanskyj; Susan M. Schwager; Curtis A. Hanson; Aya πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 144 KB

## Abstract ## BACKGROUND: Advanced age and a history of thrombosis were well‐established risk factors for thrombosis in essential thrombocythemia (ET) and polycythemia vera (PV); cytoreductive therapy was indicated in their presence. Recent studies have suggested leukocytosis as an additional ris